Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Accolade, Inc. - common stock (NQ: ACCD )

6.900 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Accolade, Inc. - common stock

< Previous 1 2 Next >
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
From Kahn Swick & Foti, LLC
Via Business Wire
Accolade Inc. (NASDAQ: ACCD) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Transcarent To Acquire Accolade
From Transcarent
Via Business Wire
Transcarent To Acquire Accolade
From Accolade, Inc.
Via GlobeNewswire
Accolade Announces Results for Fiscal Second Quarter 2025
From Accolade, Inc.
Via GlobeNewswire
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm
From The Schall Law Firm
Via Business Wire
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
From Accolade, Inc.
Via GlobeNewswire
Accolade Announces Results for Fiscal Third Quarter 2024
From Accolade, Inc.
Via GlobeNewswire
Accolade Announces Results for Fiscal Second Quarter 2024
From Accolade, Inc.
Via GlobeNewswire
MarketBeat Week in Review – 7/10 - 7/14
As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Accolade: A Rising Personalized AI-Powered Healthcare Platform
Accolade Inc. (NASDAQ: ACCD) provides an artificial intelligence (AI)-powered healthcare platform. Learn more about Accolade Inc. stock. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Accolade Announces Results for Fiscal First Quarter 2024
From Accolade, Inc.
Via GlobeNewswire
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023
From Accolade, Inc.
Via GlobeNewswire
Accolade Inc. (NASDAQ: ACCD) Records 52-Week High Thursday Morning
Via Investor Brand Network
Accolade Inc. (NASDAQ: ACCD) Records 52-Week High Wednesday Morning
Via Investor Brand Network
Accolade Announces Results for Fiscal Third Quarter 2023
From Accolade, Inc.
Via GlobeNewswire
Accolade Announces Results for Fiscal Second Quarter 2023
From Accolade, Inc.
Via GlobeNewswire
Priority Health announces launch of new health navigation solution, PriorityGPS™
From Priority Health
Via Business Wire
Accolade Moves Higher But Growth Is Slowing
Accolade (NASDAQ: ACCD) is certainly an interesting play on the health care space providing business and employee services geared toward helping clients navigate the cumbersome health benefits arena.... 
Via MarketBeat
NASDAQ: ACCD Investor Alert: Investigation over Potential Wrongdoing at Accolade, Inc.
San Diego, CA -- (SBWIRE) -- 06/16/2022 -- An investigation on behalf of investors in Accolade, Inc. (NASDAQ: ACCD) shares over potential wrongdoing at Accolade, Inc. was announced. 
Via SBWire
NASDAQ:ACCD Shareholder Notice: Investigation over Potential Securities Laws Violations by Accolade, Inc.
San Diego, CA -- (SBWIRE) -- 05/10/2022 -- An investigation was announced over potential securities laws violations by Accolade, Inc. in connection with certain financial statements. 
Via SBWire
Ongoing Investigation Notice: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings
Exposures Financial
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings
Exposures Financial
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings
Exposures Financial
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.